[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"infection-due-to-carbapenem-resistant-acinetobacter\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:infection-due-to-carbapenem-resistant-acinetobacter":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":21,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100559954",false,"NCT06570850","Colistin Monotherapy vs Colsitin-fosfomycine in CRAB Infection","Efficacy of Colistin Monotherapy Versus Colistin Combined With Fosfomycin Against Carbapenem-Resistant Acinetobacter Baumannii Infections","Inclusion Criteria:\n\n* ≥ 20 years old patients who have CRAB infections (pneumonia, urinary tract infection, skin and soft tissue infection, bloodstream infection)\n* Able to provide informed consent or having a legal proxy who can provide informed consent in case the subject is unable to provide consent on his own\n\nExclusion Criteria:\n\n* Minimum inhibitory concentration (MIC) of colistin \\> 2 mg\u002FL\n* Complicated infection with inadequate source controlled\n* Intracranial infection\n* Infective endocarditis\n* Intraabdominal infection\n* Bone and joint infection\n* Allergic to or have contraindication(s) to any treatment regimen in the study\n* Polymicrobial infection with Carbapenem-resistant Psuedomonas aeruginosa, Carbapenem-resistant Enterobacterales (CRE), Vancomycin-resistant Enterococcus (VRE)\n* Pregnancy\n* Previous treatment with colistin or fosfomycin more than 96 hours\n* Life expectancy of 24 hour or less\n* Refusal to participate in the study\n* Hospice treatment","ALL","20 Years",{"count":18,"type":19},188,"ESTIMATED","INTERVENTIONAL",[22],"PHASE4","The goal of this clinical trial is to evaluate the efficacy of colistin compared with colistin plus fosfomycin against carbapenem-resistant Acinetobacter baumanii infection in Thailand. The main questions it aims to answer the following main questions:\n\n1. Which group has better clinical response at end of treatment\n2. Which group has better clinical response at 72 hours and micrological cure at 72 hours and at end of treatment",[25],"Infection Due to Carbapenem Resistant Acinetobacter",[27,28,29,30],"carbapenem resistant Acinetobacter baumanni","CRAB","Colistin","Fosfomycin","RECRUITING","2024-08-22",{"date":34,"type":35},"2024-08-26","ACTUAL",{"date":37,"type":35},"2023-04-01",{"date":39,"type":19},"2025-07",{"name":41,"class":42},"Chiang Mai University","OTHER",""]